Search clinical trials for: Immediate Release Sublingual Buprenorphine
Total 308 results
-
NYU Langone HealthNational Institute on Drug Abuse (NIDA); The Emmes Company, LLCCompletedOpioid Use DisorderUnited States
-
University of RochesterTerminated
-
AstraZenecaCompleted
-
University of MinnesotaCompletedKidney Transplant Failure and RejectionUnited States
-
GlaxoSmithKlineCompletedParkinson DiseaseSpain, France, Bulgaria, United Kingdom, Germany, Hungary, Russian Federation, South Africa, Italy, Canada, Czechia, Poland, Romania, Ukraine
-
Diurnal LimitedCompletedCongenital Adrenal HyperplasiaFrance, United States, Japan
-
Galderma R&DCompletedPapulopustular RosaceaUnited States
-
Paolo MannelliAlkermes, Inc.CompletedLow Dose Naltrexone-buprenorphine Transfer to Vivitrol Injection in Opioid Dependence (BUP/NXT-VIVI)Opiate DependenceUnited States
-
Boehringer IngelheimCompletedHIV InfectionsUnited States, Botswana, Germany, South Africa
-
Azurity PharmaceuticalsCompletedAbuse PotentialUnited States
-
PfizerCompletedHealthy ParticipantsBelgium
-
Mundipharma Research LimitedTerminatedPolymyalgia RheumaticaUnited Kingdom
-
Dinora, Inc.PharPoint Research, Inc.; Analgesic SolutionsTerminated
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
University of OsloNorwegian Institute of Public Health; Oslo University Hospital; The Research... and other collaboratorsCompletedOpioid DependenceNorway
-
Cedars-Sinai Medical CenterVeloxis PharmaceuticalsActive, not recruitingKidney Transplant RejectionUnited States
-
Boehringer IngelheimCompletedParkinson DiseaseFrance, Germany, Netherlands
-
Diurnal LimitedNational Institutes of Health Clinical Center (CC)CompletedAdrenogenital Syndrome | Congenital Adrenal Hyperplasia | 21-Hydroxylase DeficiencyUnited States
-
Boehringer IngelheimCompleted
-
PfizerCompletedHealthy ParticipantsBelgium
-
Boehringer IngelheimCompleted
-
University of PennsylvaniaCompletedHealthy VolunteersUnited States
-
Sarfez Pharmaceuticals, Inc.Sarfez Pharmaceuticals, Inc.Recruiting
-
Galderma R&DCompletedRosaceaUnited States, Canada, Hungary
-
Boehringer IngelheimCompletedEarly Parkinson Disease (Early PD)United States, Argentina, Austria, Czech Republic, Finland, Germany, Hungary, India, Japan, Malaysia, Russian Federation, Slovakia, Taiwan, Ukraine
-
Horizon Pharma Ireland, Ltd., Dublin IrelandCompleted
-
Chinese Association of Geriatric ResearchCompleted
-
Boehringer IngelheimCompletedParkinson DiseaseAustria, Czech Republic, Hungary, India, Italy, Korea, Republic of, Philippines, Poland, Russian Federation, Slovakia, Spain, Sweden, Ukraine, United Kingdom
-
Ferring PharmaceuticalsCompleted
-
Boehringer IngelheimCompleted
-
Alza Corporation, DE, USACompleted
-
Emalex Biosciences Inc.Psyadon PharmaCompleted
-
Ferrer Internacional S.A.Completed
-
AstraZenecaTerminatedPsychotic Disorders | Schizophrenia | Schizoaffective DisordersUnited Kingdom
-
University Hospital Schleswig-HolsteinRecruiting
-
University of British ColumbiaPaladin Labs Inc.RecruitingLiver Transplantation | Neurotoxicity | Tremor | Tacrolimus | ImmunosuppressionCanada
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics of YM178Netherlands
-
Terran Biosciences Australia Pty LtdRecruiting
-
Yungjin Pharm. Co., Ltd.Chonbuk National University HospitalCompleted
-
The University of Texas Health Science Center,...National Institute of Mental Health (NIMH)CompletedAutism | Attention Deficit Disorder With HyperactivityUnited States
-
AmgenCompletedHealthy VolunteersUnited States
-
Mayo ClinicNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...CompletedConstipationUnited States
-
AstraZenecaCompleted
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); BayerTerminatedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerUnited States
-
Applied Science & Performance InstituteRecruitingCognitive Change | Mood | Caffeine | Mood ChangeUnited States